SER
Serina Therapeutics Inc (SER) Investor Questions
Review Serina Therapeutics Inc (SER) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Serina Therapeutics Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 49
- Annual revenue
- $130,000.00
- Annual net income
- $-19.18M
- Annual free cash flow
- $-17.95M
Serina Therapeutics Inc (SER) Investor Questions research
Serina Therapeutics Inc trades under the ticker SER. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review SER through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.